Cranberry oil soothing formulation for intimate health
A cranberry oil formulation offering synergistic effects with antifungal agents against Candida albicans, enhancing comfort and preventing dysbiosis. Validated in vitro, the solution invites partnerships for in vivo studies to further explore its benefits.
Overview
Givaudan has developed a cranberry oil formulation designed to improve intimate health by providing synergistic effects with common antifungal agents, such as Clotrimazol. This innovative solution targets Candida albicans, a common cause of yeast infections, while enhancing user comfort and preventing dysbiosis. Cranberry oil has demonstrated significant anti-inflammatory properties, including a 36% reduction in IL-6 levels, and promotes a healthy vaginal microbiota.
Technical specifications
Key features:
- Demonstrated reduction of Candida albicans by 103% and Gardnerella vaginalis by 96%
- Increased Lactobacillus jensenii by 66 times at a concentration of 0.5%
- Restores pH acidity, inhibiting the growth of pathogenic bacteria and supporting commensal bacteria
- Potential for synergistic use with Clotrimazol for enhanced antifungal effects
Technology readiness level
This cranberry oil formulation has reached Technology Readiness Level 6, indicating that it has been validated in vitro. Givaudan is actively seeking partnerships to initiate in vivo studies, aiming to further validate the efficacy and safety of this promising formulation for intimate care.
About Givaudan
Our long-term purpose goals include an emphasis on our people, the 16,260 employees of more than 90 nationalities globally who form the foundation of our business: we are committed to providing a safe, healthy and inclusive work environment where everyone loves to be and grow.
delivered to your inbox.